Filing Details
- Accession Number:
- 0001127602-23-019198
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-22 08:33:09
- Reporting Period:
- 2023-06-21
- Accepted Time:
- 2023-06-22 08:33:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1591312 | I Bassil Dahiyat | C/O Xencor, Inc. 465 N Halstead Street, Suite 200 Pasadena CA 91107 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-06-21 | 76,012 | $4.25 | 325,713 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-06-21 | 33,497 | $26.19 | 292,216 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-06-21 | 76,012 | $0.00 | 76,012 | $4.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-09-04 | 2023-09-03 | No | 4 | M | Direct |
Footnotes
- Underlying option due to expire in September 2023.
- Represents the disposition of shares sold to pay option cost and estimated tax liability due upon option exercise.
- Represents first vesting date. Option vested over four years from date of grant.
Billionaire Hedge Funds
